Current Opinion in Biomedical Engineering is a renowned journal published by Elsevier, focusing on the cutting-edge developments and critical assessments in the fields of biomedical engineering and related disciplines. With an ISSN of 2468-4511, it provides a valuable platform for researchers and professionals to disseminate their insights and discoveries in areas such as bioengineering, biomaterials, and medicine. Its impressive impact factor positions it in the Q2 category for several fields, including Bioengineering and Biomedical Engineering, highlighting its influence and relevance in ongoing scientific dialogues. The journal’s unique format of opinion pieces and reviews encourages innovative thinking and fosters collaboration among experts. As an essential resource for those engaged in the life sciences and engineering, Current Opinion in Biomedical Engineering serves to stimulate discussion, promote knowledge exchange, and drive advancements in biomedical applications. Set in the Netherlands at Radarweg 29, 1043 NX Amsterdam, the journal is accessible through various academic platforms, enabling a global readership to engage with the latest scholarly work in this dynamic field.

Tissue Engineering Part B-Reviews is a premier academic journal published by MARY ANN LIEBERT, INC, focusing on the interdisciplinary field of tissue engineering and regenerative medicine. With an impressive impact factor that places it in the Q1 category across multiple relevant fields—including Biochemistry, Bioengineering, Biomaterials, and Biomedical Engineering—this journal provides a vital platform for researchers and professionals to disseminate cutting-edge findings and comprehensive reviews. Covering a vast scope from 2008 to 2024, the journal is committed to advancing knowledge in the application of engineering principles to biological tissues, making it an indispensable resource for those at the forefront of biomedical innovation. While the journal does not currently offer open access options, its rigorous peer review process ensures high-quality contributions that are essential for academic and practical advancements. The journal's rankings in Scopus reflect its significance, catering to a diverse audience of students, researchers, and practitioners seeking the latest insights in this dynamic field.

Frontiers in Bioengineering and Biotechnology, published by FRONTIERS MEDIA SA in Switzerland, stands as a leading platform for innovative research and developments in the fields of bioengineering and biotechnology. Since its inception in 2013, this Open Access journal has garnered significant recognition, reflected in its impressive category rankings: Q1 in Biomedical Engineering and Q2 in Bioengineering, Biotechnology, and Histology for 2023. With a focus on fostering collaboration and knowledge sharing, it aims to provide researchers, professionals, and students with access to pioneering studies that push the boundaries of science and technology. The journal, which is indexed in prominent databases, boasts high visibility and impact, evidenced by its impressive rankings across various categories in Scopus. As it continues to converge from 2013 to 2024, Frontiers in Bioengineering and Biotechnology is dedicated to shaping the discourse in its field and promoting advancements that have the potential to transform healthcare and environmental sustainability.

BIOMEDICAL MICRODEVICES is a leading journal published by Springer that focuses on the innovative field of microdevices within biomedical engineering. With an ISSN of 1387-2176 and an E-ISSN of 1572-8781, BIOMEDICAL MICRODEVICES offers a prestigious platform for researchers to disseminate their findings from 1998 to 2024, demonstrating a long-standing commitment to advancing knowledge in this critical area. The journal is recognized for its significant contributions, boasting a Q2 ranking in Biomedical Engineering and Nanoscience and Nanotechnology, and a Q3 rank in Molecular Biology. Renowned for its rigorous peer-review process, it is positioned within the top 30% of its field according to Scopus rankings, making it a valuable resource for researchers and practitioners alike. Though it operates under a subscription model, the emphasis on quality and relevance within its scope ensures that BIOMEDICAL MICRODEVICES remains a vital source of cutting-edge research that bridges engineering and biological systems, fostering innovation and collaboration in the pursuit of novel health solutions.

Biomedical Engineering Letters, published by SpringerNature, is a prominent journal in the field of Biomedical Engineering. With a robust ISSN of 2093-9868 and E-ISSN of 2093-985X, this esteemed journal has established itself as a vital resource for researchers and professionals seeking to advance their knowledge and share groundbreaking findings. Recognized for its quality, Biomedical Engineering Letters holds a distinguished ranking in Scopus, positioned at #94/303 (69th percentile) in the Biomedical Engineering category. The journal covers a diverse scope within biomedical engineering, providing an important platform for innovative research from 2011 to 2024 and facilitating the exchange of ideas among scholars. Although it operates under a subscription model, the journal's commitment to enhancing the field makes it an indispensable reference for those engaged in cutting-edge biomedical research in Germany and globally.

VIEW is a prestigious journal published by WILEY that focuses on the rapidly evolving fields of Biomaterials and Biomedical Engineering. Since its inception in 2020, VIEW has established itself as an open-access platform dedicated to disseminating high-quality research and innovation within these disciplines. With an impressive impact factor that places it in the Q1 category of both Biomaterials and Biomedical Engineering, VIEW ranks among the top journals in its field, boasting a 91st percentile ranking in Biomedical Engineering and an 85th percentile ranking in Materials Science. Researchers, professionals, and students are encouraged to utilize this invaluable resource, as it provides a comprehensive view of current advancements and future trends in biomaterial science and engineering. Positioned in the United Kingdom, VIEW operates as a vital scholarly communication link, fostering collaboration and knowledge sharing within an ever-growing global community.

Biomedical Engineering Online, published by BMC, is an esteemed open-access journal in the United Kingdom that has been advancing the field of biomedical engineering since its inception in 2002. With a commitment to disseminating high-quality research, the journal encompasses a broad scope, including innovative studies in biomaterials, imaging technologies, and medical applications. Recognized within the Q2 quartile for various categories such as Biomaterials and Biomedical Engineering, it ranks favorably among its peers: Rank #58 out of 333 in Radiology, and Rank #15 out of 63 in Radiological and Ultrasound Technology in the Scopus database. These rankings, coupled with an open-access model, ensure that critical advancements in medical technology are accessible to researchers, health professionals, and students globally. As it continues through its converged years from 2002 to 2024, Biomedical Engineering Online remains an invaluable resource for anyone involved in the cutting-edge intersection of engineering and medicine.

Progress in Biomedical Engineering, published by IOP Publishing Ltd, is a premier open-access journal that serves as a vital platform for the dissemination of innovative research in the field of biomedical engineering. With an impressive Q1 classification in the Biomedical Engineering category for 2023, this journal has established itself as a significant contributor to the advancement of engineering solutions that improve healthcare outcomes. Recognized for its high-quality and impactful publications, it ranks 51st out of 303 in its field on Scopus, placing it in the 83rd percentile. The journal aims to foster interdisciplinary collaboration and introduce pioneering methodologies and technologies that bridge the gap between engineering and medicine. By providing a pathway for rapid communication of fundamental and applied research, Progress in Biomedical Engineering is dedicated to shaping the future of healthcare technology. Access to its content ensures that researchers, professionals, and students remain at the forefront of biomedical innovation.

Biomedical Materials, published by IOP Publishing Ltd, is a premier journal dedicated to the rapidly evolving field of biomedical engineering and materials science. With a robust impact factor showcasing its influence, this journal serves as a vital platform for disseminating pioneering research from 2006 to 2024. Covering an array of interdisciplinary topics—ranging from biomaterials to bioengineering and applied chemistry—the journal consistently ranks in the second quartile across multiple categories including Bioengineering (Q2), Biomaterials (Q2), and Biomedical Engineering (Q2) as of 2023. Researchers, professionals, and students alike benefit from its contributions, exploring innovative solutions at the intersection of biology and material science. Although not an Open Access journal, Biomedical Materials remains essential in advancing our understanding and facilitating discussions surrounding state-of-the-art materials that revolutionize medical applications and enhance patient care.

Acta Biomaterialia, published by Elsevier Science Ltd, is a leading journal in the fields of biochemistry, biomaterials, biomedical engineering, biotechnology, and molecular biology. With an ISSN of 1742-7061 and an E-ISSN of 1878-7568, this prestigious journal has secured a remarkable position in the academic community, evidenced by its inclusion in the Q1 category across multiple disciplines for 2023. It ranks impressively at #21 in biochemistry, #16 in biomedical engineering, #18 in biotechnology, and #11 in biomaterials, reflecting its high impact and relevance to ongoing research and development. The journal provides a platform for disseminating innovative research and advancements in the design and application of biomaterials, contributing to scientific discussions that propel the field forward. Although it does not currently offer open access options, Acta Biomaterialia continues to attract contributions that advance our understanding of biomaterials and their interactions with biological systems, ensuring that researchers, professionals, and students remain informed about the latest trends and breakthroughs in this rapidly evolving area of study.